| CEO Name | Jay Mazelsky |
| Nationality | United States |
| Net Worth Estimation | $50 million |
Jay Mazelsky's estimated net worth of around $50 million primarily derives from his compensation as CEO of IDEXX Laboratories and substantial holdings of the company's stock. His wealth is influenced by base salary, bonuses, stock awards, and stock option exercises tied to IDEXX's strong financial performance.
Jay Mazelsky, CEO of IDEXX Laboratories in the veterinary sector, has an estimated net worth of $50,000,000--representing 72% of the maximum ($70,000,000) and 50 times the minimum ($1,000,000) estimated CEO net worths in this category. His wealth places him well above the average for industry leaders.
Business Category: Veterinary
Minimum Net Worth (estimation): 1000000 USD
Maximum Net Worth (estimation): 70000000 USD
Jay Mazelsky Performance in IDEXX Laboratories
Jay Mazelsky, CEO of IDEXX Laboratories, demonstrates strategic leadership by driving innovation and expanding global market presence. His data-driven decision-making enhances operational efficiency and accelerates product development in veterinary diagnostics. Under his performance, IDEXX has achieved sustained revenue growth and strengthened industry leadership.
Latest News
IDEXX Laboratories Delivers Double-Digit Revenue and EPS Growth, Boosts Outlook for 2025
IDEXX Laboratories reported a 13% year-over-year revenue increase and a 21% EPS surge in Q3 2025, led by strong performance in its Companion Animal Group and robust adoption of new diagnostic technologies. CEO Jay Mazelsky credited the company's innovation-driven growth strategy and raised full-year guidance, reflecting confidence in continued momentum and customer trust.
Source: http://marketchameleon.com/articles/b/2025/11/3/idexx-laboratories-reports-double-digit-growth-and-raises-2025-guidance